Finzati - Logo
INDV logo

Indivior Pharmaceuticals Inc

INDV • Drug Manufacturers - Specialty & Generic
$34.94
▲ +0.11 (+0.32%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$4.93B
Growth
4.4%
Cash Flow
2/5
Trend
Volatile
Evidence
Stable or improving margins · 16.9%Positive revenue growth · 16.2%Reasonable earnings multiple · 21.36Weak liquidity · 0.71
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:51 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$34.94
Change0.32%
Market Cap$4.93B
52W Range21.69 - 42.81
Beta1.03
Gross Margin80.15%
Oper. Margin21.39%
Profit Margin16.95%
Debt/Eq-3.58
Current Ratio0.71
Quick Ratio0.55
Revenue 5Y4.40%

Investment DNA

How strong this company looks for long-term investors

60
out of 100
Business Quality
Margins, moat, returns
81/100
Financial Strength
Debt, cash, stability
36/100
Growth Potential
Revenue and expansion
58/100
Price Attractiveness
Cheap or expensive today
66/100
Why this score▼
Stable or improving margins · 16.9%Positive revenue growth · 16.2%Reasonable earnings multiple · 21.36Weak liquidity · 0.71

Analyst view

Analyst sentiment and price target

Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$43.00
Mean
$48.00
Median
$48.00
High
$53.00

Company Overview

IPO: 12/29/2014
Industry: Drug Manufacturers - Specialty & Generic
P/B i: -45.77
Debt / Equity i: -3.58
Operating Margin: 21.39%
Net Margin: 16.95%
ROE i: -
ROIC: -

Financial Health

Score7 / 20
Debt / Equity: -3.58
Current Ratio: 0.71
Quick Ratio: 0.55
Status: Weak

Warnings

  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

⚠ 3 high-volume insider sells detected
Anderson Woodrow D
Transaction: 08/05/2026
BUY
Change
+1,500
Price
$36.28
Filing
08/05/2026
Type
BUY
Heidbreder Christian
Transaction: 07/10/2026
SELL
Change
-18,586
Price
$41.14
Filing
07/13/2026
Type
SELL
Ciaffoni Joseph
Transaction: 06/22/2026
SELL
Change
-1,266,903
Price
Not reported
Filing
06/23/2026
Type
SELL